SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo

🎯 Drug Targets

Browse 2 drug targets with druggability analysis, composite scores, and clinical context

2
Targets
2
High Druggability
0.67
Avg Score
15
Target Classes
Druggability Distribution
High: 2Medium: 0Low: 0Unknown: 0
Avg druggability score: 0.900
Clinical Pipeline
Approved: 2Phase III: 0Phase II: 0Phase I: 0Preclinical: 0
Total compounds: 17 · Approved: 17
Class All Classes Enzyme (35) Signaling Protein (25) Structural Protein (17) Protein (16) Gpcr (13) Ion Channel (12) Transcription Factor (11) Receptor (11) Ligand (10) Transporter (8) Epigenetic Regulator (8) Kinase (7) Protease (4) Other (4) Chaperone (4)
Druggability All Druggability Low (100) Medium (62) High (14) Undruggable (6) other (3)
Sort Score Druggability Gene A-Z Market Price
Filtered by: class=GPCR, druggability=High — 2 results
DRD2 Dopamine receptor D2 Phase 4
Gpcr High Druggability
Score
0.69
Drug.
0.90
Safety
0.60
Drugs
14
Hyps
1
Papers
18
Small molecule agonist or antagonist modulating dopamine signaling
MTNR1B Melatonin receptor 1B Phase 4
Gpcr High Druggability
Score
0.64
Drug.
0.90
Safety
0.80
Drugs
3
Hyps
2
Papers
17
Small molecule agonists that activate G-protein coupled receptor signaling
Exchange | Dashboard